Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erika L. Baker"'
Autor:
Rana Alissa, Patty D. Williams, Erika L. Baker, Jennifer A. Hipp, Jinous Saremian, Agnes E. Aysola
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Objective: To show concordance between heel stick and placental blood sample pairs for newborns' pre-transfusion testing and to validate placental blood's tube and gel methodology.Methods: Placental samples were collected for pre-transfusion testing
Externí odkaz:
https://doaj.org/article/d4df3ed347504a968f16169c1c8dd62b
Publikováno v:
Advances in Neonatal Care. 21:87-91
Background Evidence supports the need to decrease healthcare costs. One approach may be minimizing use of low-value care by reducing the number of unnecessary neonatal intensive care unit (NICU) admissions through the use of official neonatal transit
Autor:
Erika L. Baker, Jinous Saremian, Rana Alissa, Patty D. Williams, Jennifer A. Hipp, Agnes Aysola
Publikováno v:
Frontiers in Pediatrics
Frontiers in Pediatrics, Vol 9 (2021)
Frontiers in Pediatrics, Vol 9 (2021)
Objective: To show concordance between heel stick and placental blood sample pairs for newborns' pre-transfusion testing and to validate placental blood's tube and gel methodology.Methods: Placental samples were collected for pre-transfusion testing
Publikováno v:
Pediatrics. 147:316-317
Title: Four Years after Donor Milk Implementation in Our Mother-Baby Unit: How Are We Doing? Background: The World Health Organization (WHO) and the American Academy of Pediatrics (AAP) recommend exclusive breastfeeding for the first 6 months of life
Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review
Autor:
Olivia P. Phung, Jeffrey Kluger, C Michael White, William L. Baker, Ripple Talati, Craig I Coleman, Ajibade Ashaye, Erika L. Baker, Jennifer M Scholle
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 32:314-322
Generic antiepileptic drugs achieve blood concentrations similar to those of innovator drugs in healthy volunteers, but their comparative effectiveness has not been well evaluated. Thus, we assessed the efficacy, tolerability, and safety of innovator